These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 11425542

  • 1. Some 3-thioxo/alkylthio-1,2,4-triazoles with a substituted thiourea moiety as possible antimycobacterials.
    Küçükgüzel I, Küçükgüzel SG, Rollas S, Kiraz M.
    Bioorg Med Chem Lett; 2001 Jul 09; 11(13):1703-7. PubMed ID: 11425542
    [Abstract] [Full Text] [Related]

  • 2. Synthesis of some novel thiourea derivatives obtained from 5-[(4-aminophenoxy)methyl]-4-alkyl/aryl-2,4-dihydro-3H-1,2,4-triazole-3-thiones and evaluation as antiviral/anti-HIV and anti-tuberculosis agents.
    Küçükgüzel I, Tatar E, Küçükgüzel SG, Rollas S, De Clercq E.
    Eur J Med Chem; 2008 Feb 09; 43(2):381-92. PubMed ID: 17583388
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of antimycobacterial and anticonvulsant activities of new 1-(4-fluorobenzoyl)-4-substituted-thiosemicarbazide and 5-(4-fluorophenyl)-4-substituted-2,4-dihydro-3H-1,2,4-triazole-3-thione derivatives.
    Gülerman N, Rollas S, Kiraz M, Ekinci AC, Vidin A.
    Farmaco; 1997 Nov 09; 52(11):691-5. PubMed ID: 9550096
    [Abstract] [Full Text] [Related]

  • 4. A convenient synthesis and screening of benzosuberone bearing 1,2,3-triazoles against Mycobacterium tuberculosis.
    Sajja Y, Vanguru S, Jilla L, Vulupala HR, Bantu R, Yogeswari P, Sriram D, Nagarapu L.
    Bioorg Med Chem Lett; 2016 Sep 01; 26(17):4292-5. PubMed ID: 27476139
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and antituberculosis activity of new N-phenyl-N'-[4-(5-alkyl/arylamino-1,3,4-thiadiazole-2-yl)phenyl]thioureas.
    Karakuş S, Rollas S.
    Farmaco; 2002 Jul 01; 57(7):577-81. PubMed ID: 12164218
    [Abstract] [Full Text] [Related]

  • 6. Design, synthesis and evaluation of 1,2,3-triazole-adamantylacetamide hybrids as potent inhibitors of Mycobacterium tuberculosis.
    Addla D, Jallapally A, Gurram D, Yogeeswari P, Sriram D, Kantevari S.
    Bioorg Med Chem Lett; 2014 Apr 15; 24(8):1974-9. PubMed ID: 24679703
    [Abstract] [Full Text] [Related]

  • 7. Rational design and synthesis of novel dibenzo[b,d]furan-1,2,3-triazole conjugates as potent inhibitors of Mycobacterium tuberculosis.
    Yempala T, Sridevi JP, Yogeeswari P, Sriram D, Kantevari S.
    Eur J Med Chem; 2014 Jan 15; 71():160-7. PubMed ID: 24292337
    [Abstract] [Full Text] [Related]

  • 8. Novel 1,2,3-triazole derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain.
    Boechat N, Ferreira VF, Ferreira SB, de Lourdes G Ferreira M, de C da Silva F, Bastos MM, Dos S Costa M, Lourenço MC, Pinto AC, Krettli AU, Aguiar AC, Teixeira BM, da Silva NV, Martins PR, Bezerra FA, Camilo AL, da Silva GP, Costa CC.
    J Med Chem; 2011 Sep 08; 54(17):5988-99. PubMed ID: 21776985
    [Abstract] [Full Text] [Related]

  • 9. The structure--antituberculosis activity relationships study in a series of 5-(4-aminophenyl)-4-substituted-2,4-dihydro-3h-1,2,4-triazole-3-thione derivatives. A combined electronic-topological and neural networks approach.
    Kandemirli F, Shvets N, Unsalan S, Küçükgüzel I, Rollas S, Kovalishyn V, Dimoglo A.
    Med Chem; 2006 Jul 08; 2(4):415-22. PubMed ID: 16848755
    [Abstract] [Full Text] [Related]

  • 10. Fluorinated 1,2,4-Triazolo[1,5-a]pyrimidine-6-carboxylic acid derivatives as antimycobacterial agents.
    Abdel-Rahman HM, El-Koussi NA, Hassan HY.
    Arch Pharm (Weinheim); 2009 Feb 08; 342(2):94-9. PubMed ID: 19173243
    [Abstract] [Full Text] [Related]

  • 11. Imidazole and 1,2,4-Triazole-based Derivatives Gifted with Antitubercular Activity: Cytotoxicity and Computational Assessment.
    Zampieri D, Cateni F, Moneghini M, Zacchigna M, Laurini E, Marson D, De Logu A, Sanna A, Mamolo MG.
    Curr Top Med Chem; 2019 Feb 08; 19(8):620-632. PubMed ID: 30827247
    [Abstract] [Full Text] [Related]

  • 12. Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids.
    Addla D, Jallapally A, Gurram D, Yogeeswari P, Sriram D, Kantevari S.
    Bioorg Med Chem Lett; 2014 Jan 01; 24(1):233-6. PubMed ID: 24314670
    [Abstract] [Full Text] [Related]

  • 13. Design, synthesis and biological evaluation of novel 1,2,3-triazole analogues of Imidazo-[1,2-a]-pyridine-3-carboxamide against Mycobacterium tuberculosis.
    Nandikolla A, Srinivasarao S, Khetmalis YM, Kumar BK, Murugesan S, Shetye G, Ma R, Franzblau SG, Sekhar KVGC.
    Toxicol In Vitro; 2021 Aug 01; 74():105137. PubMed ID: 33684466
    [Abstract] [Full Text] [Related]

  • 14. Application of Huisgen (3+2) cycloaddition reaction: synthesis of 1-(2,3-dihydrobenzofuran-2-yl-methyl [1,2,3]-triazoles and their antitubercular evaluations.
    Tripathi RP, Yadav AK, Ajay A, Bisht SS, Chaturvedi V, Sinha SK.
    Eur J Med Chem; 2010 Jan 01; 45(1):142-8. PubMed ID: 19846238
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and biological evaluation of 1,2,4-triazole-3-thione and 1,3,4-oxadiazole-2-thione as antimycobacterial agents.
    Sonawane AD, Rode ND, Nawale L, Joshi RR, Joshi RA, Likhite AP, Sarkar D.
    Chem Biol Drug Des; 2017 Aug 01; 90(2):200-209. PubMed ID: 28083914
    [Abstract] [Full Text] [Related]

  • 16. Antimycobacterial activity of novel 1-(5-cyclobutyl-1,3-oxazol-2-yl)-3-(sub)phenyl/pyridylthiourea compounds endowed with high activity toward multidrug-resistant Mycobacterium tuberculosis.
    Sriram D, Yogeeswari P, Dinakaran M, Thirumurugan R.
    J Antimicrob Chemother; 2007 Jun 01; 59(6):1194-6. PubMed ID: 17449482
    [Abstract] [Full Text] [Related]

  • 17. Sequential synthesis of amino-1,4-naphthoquinone-appended triazoles and triazole-chromene hybrids and their antimycobacterial evaluation.
    Devi Bala B, Muthusaravanan S, Choon TS, Ashraf Ali M, Perumal S.
    Eur J Med Chem; 2014 Oct 06; 85():737-46. PubMed ID: 25129868
    [Abstract] [Full Text] [Related]

  • 18. Design and synthesis of 1H-1,2,3-triazoles derived from econazole as antitubercular agents.
    Kim S, Cho SN, Oh T, Kim P.
    Bioorg Med Chem Lett; 2012 Nov 15; 22(22):6844-7. PubMed ID: 23058885
    [Abstract] [Full Text] [Related]

  • 19. Discovery of new 1,3,5-triazine scaffolds with potent activity against Mycobacterium tuberculosis H37Rv.
    Sunduru N, Gupta L, Chaturvedi V, Dwivedi R, Sinha S, Chauhan PM.
    Eur J Med Chem; 2010 Aug 15; 45(8):3335-45. PubMed ID: 20452706
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis, and characterization of (1-(4-aryl)- 1H-1,2,3-triazol-4-yl)methyl, substituted phenyl-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylates against Mycobacterium tuberculosis.
    Venugopala KN, Dharma Rao GB, Bhandary S, Pillay M, Chopra D, Aldhubiab BE, Attimarad M, Alwassil OI, Harsha S, Mlisana K.
    Drug Des Devel Ther; 2016 Aug 15; 10():2681-90. PubMed ID: 27601885
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.